GeoVax Labs Inc (GOVX)

[3CTraderIsBack]

https://finance.yahoo.com/news/geovax-sino-biological-establish-exclusive-130010304.html

GeoVax is at the forefront of development for a COVID-19 vaccine and its use of recombinant viruses to generate virus-like particles (VLPs) in vivo has demonstrated considerable immune response for other viruses in a number of human clinical trials.

GeoVax’s unique VLP-generation technology is exciting, and its commitment to the development of a vaccine for COVID-19 is inspiring. We at Sino Biological are honored to be the exclusive provider of COVID-19-related research reagents to assist their vaccine development efforts,” commented Rob Burgess, Ph.D., Chief Business Officer for Sino Biological.